Phase 3 Schizophrenia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with schizophrenia as their primary condition
- People who are able to stop taking certain medications before the study begins, including antipsychotics, if they are currently taking any
- People who have a stable, secure living situation
Who may not be able to join:
- People who have a known allergic reaction or sensitivity to any ingredient in the study drug, NBI-1117568
- People who have an unstable or poorly managed ongoing medical condition or chronic illness
- People whom the trial doctor considers to be at immediate risk of harming themselves or others
- People who have been diagnosed with a moderate or severe problem with substance use (other than nicotine or caffeine dependence) within the six months before screening
- People who test positive for alcohol or disallowed substances at the time of screening
- People who have a history of not following study rules in previous clinical research, or whom the trial doctor believes would not be able to follow the requirements of this study
Important: Always verify eligibility with the trial site directly before applying.
Note: There may be additional criteria not listed here. The trial site will assess all requirements in full.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Clinical Development Lead, Neurocrine Biosciences
Phone: 877-641-3461
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of Participants with Treatment-emergent Adverse Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.